NIGP 26978: Radioactive Pharmaceuticals

NIGP 26978 Radioactive Pharmaceuticals, an Item code, covers radiopharmaceutical products—nuclear medicine compounds used in diagnostic imaging and therapeutic applications within state and local healthcare systems. State and local governments procure these substances primarily through hospital networks, health departments, and integrated delivery systems that operate nuclear medicine departments and oncology programs. The code encompasses radioisotope-based diagnostics (such as technetium and iodine compounds) and therapeutic radiopharmaceuticals used in cancer treatment and other clinical applications. Purchasing entities include state health departments, county hospital systems, municipal teaching hospitals, and specialized cancer treatment centers, though the specialized nature of nuclear medicine limits the breadth of issuing bodies compared to broader pharmaceutical codes.

The source provided contains no recent state and local contract opportunities under this code. Without posted RFPs, RFQs, or ITB notices, the current market activity level and geographic concentration cannot be characterized from recent solicitation data.